174 related articles for article (PubMed ID: 2124530)
1. Effects of immunomodulating therapy in systemic sclerosis.
van den Hoogen FH; Boerbooms AM; van de Putte LB
Clin Rheumatol; 1990 Sep; 9(3):319-24. PubMed ID: 2124530
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy. 1.
Skinner MD; Schwartz RS
N Engl J Med; 1972 Aug; 287(5):221-7. PubMed ID: 4556641
[No Abstract] [Full Text] [Related]
3. Multiple sclerosis and systemic sclerosis: efficacy of interferon beta on skin lesions.
Carrieri PB; Petracca M; Montella S; Delfino M; Sepe C; Gattoni A
Ann Rheum Dis; 2008 Aug; 67(8):1192-3. PubMed ID: 18621969
[No Abstract] [Full Text] [Related]
4. The use of immunosuppressive drugs in uveitis.
Carnahan MC; Goldstein DA
Dev Ophthalmol; 1999; 31():132-59. PubMed ID: 10641205
[No Abstract] [Full Text] [Related]
5. Immunosuppression and immunomodulation.
Goust JM; Stevenson H; Galbraith R; Virella G
Immunol Ser; 1993; 58():465-80. PubMed ID: 8424989
[No Abstract] [Full Text] [Related]
6. Treatment of systemic sclerosis.
Medsger TA
Curr Opin Rheumatol; 1990 Dec; 2(6):956-9. PubMed ID: 2128028
[No Abstract] [Full Text] [Related]
7. Clinical trials of immunosuppression and immunomodulation in multiple sclerosis.
Kappos L
J Neuroimmunol; 1988 Dec; 20(2-3):261-8. PubMed ID: 3058744
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine therapy for severe systemic sclerosis associated with the anti-Scl-70 autoantibody.
Vayssairat M; Baudot N; Boitard C; Fiessinger JN; Bach JF
J Am Acad Dermatol; 1990 Apr; 22(4):695-6. PubMed ID: 2319032
[No Abstract] [Full Text] [Related]
9. [Immunosuppressive therapy].
Schumacher K; Gross R
Internist (Berl); 1984 Jan; 25(1):51-9. PubMed ID: 6370894
[No Abstract] [Full Text] [Related]
10. Treatment with interferon gamma enhances fibrinolysis in systemic sclerosis.
Gluszko P; Undas A; Kwasny B; Musiał J; Szczeklik A
Thromb Res; 1998 Aug; 91(4):203-7. PubMed ID: 9736424
[No Abstract] [Full Text] [Related]
11. Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial.
Grassegger A; Schuler G; Hessenberger G; Walder-Hantich B; Jabkowski J; MacHeiner W; Salmhofer W; Zahel B; Pinter G; Herold M; Klein G; Fritsch PO
Br J Dermatol; 1998 Oct; 139(4):639-48. PubMed ID: 9892907
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A in progressive systemic sclerosis.
Yocum DE; Wilder RL
Am J Med; 1987 Aug; 83(2):369-70. PubMed ID: 3618643
[No Abstract] [Full Text] [Related]
13. Cyclosporin A in systemic sclerosis.
Zachariae H; Zachariae E
Br J Dermatol; 1987 May; 116(5):741-2. PubMed ID: 3593641
[No Abstract] [Full Text] [Related]
14. Juvenile scleroderma.
Athreya BH
Curr Opin Rheumatol; 2002 Sep; 14(5):553-61. PubMed ID: 12192254
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine in successful control of rapidly progressive scleroderma.
Appelboom T; Itzkowitch D
Am J Med; 1987 Apr; 82(4):866-7. PubMed ID: 3565449
[No Abstract] [Full Text] [Related]
16. Therapeutic interventions in systemic sclerosis.
van den Hoogen FH
Neth J Med; 1998 Sep; 53(3):137-8. PubMed ID: 9803147
[No Abstract] [Full Text] [Related]
17. [Systemic sclerosis: drugs and new therapeutic methods].
Skretkowicz K; Waszczykowska E; Dziankowska-Bartkowiak B
Pol Merkur Lekarski; 2003 Sep; 15(87):263-7. PubMed ID: 14679854
[TBL] [Abstract][Full Text] [Related]
18. [Immune modulating effect of intravenous gamma globulin in a patient with overlapping syndrome].
Jurlow E; Poblete P; Marinovic MA
Rev Med Chil; 1998 Sep; 126(9):1108-11. PubMed ID: 9922516
[TBL] [Abstract][Full Text] [Related]
19. Systemic sclerosis.
Ng SC
Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127
[TBL] [Abstract][Full Text] [Related]
20. Application of interferon-gamma containing gel for local treatment of skin ulcers in autoimmune vasculitides and skin changes in progressive systemic sclerosis.
Arnaudova P; Rashkov R; Tsanev R
J Rheumatol; 1993 Aug; 20(8):1445-6. PubMed ID: 8230042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
